Rheumatoid Arthritis and Pregnancy Study Update

Download Report

Transcript Rheumatoid Arthritis and Pregnancy Study Update

Asthma and Asthma
Medications in Pregnancy
Study
A Vaccines and Medications in Pregnancy
Survelliance System (VAMPSS) Project
OTIS ANNUAL RESEARCH MEETING
JUNE 2010
VAMPSS Project
Vaccines and Medications in Pregnancy Surveillance System
“VAMPSS”
A Collaboration of:
American Academy of Allergy Asthma and Immunology
Organization of Teratology Information Specialist (OTIS)
Slone Epidemiology Center at Boston University (SEC)
VAMPSS Project
 VAMPSS is a new nationwide post-marketing surveillance
system established to comprehensively monitor the use
and safety of vaccines and medications during pregnancy
 The VAMPSS system provides a coordinated effort
involving:
1. prospective registry surveillance coordinated by OTIS
2. case-control surveillance coordinated by SEC
Asthma and Asthma Medications in Pregnancy Study-A
VAMPSS Project
 Study began in November 2009
 Prospective, observational cohort study
 Coordinating center is at the University of California, San
Diego
Purpose
 The Asthma and Asthma Medications in Pregnancy
study is researching the effects of short-acting and
long-acting beta agonists used for the treatment of
asthma in pregnancy
Study Participation
 Self-enrollment
 4-5 phone interviews (intake, 20wk, 32wk, outcome,
and 6 month post-partum)
 Medical records pertaining to the pregnancy and
outcome of the pregnancy
Total Enrollment to Date
Total as of June 7,
2010
Short-acting Betaagonists
9
Long-acting Betaagonists
13
Controls
13
Total Enrolled
35
Who Should be Referred?
Groups
Criteria
Short-Acting Beta
Agonist
• Diagnosed with asthma
• Exposure to a short-acting beta agonist
• Less than 20 weeks gestation
Long-Acting Beta
Agonist
• Diagnosed with asthma
• Exposure to a long-acting beta agonist
(Formoterol or Salmeterol)
• Less than 20 weeks gestation
Non-Disease Controls
• Pregnant women who are less than 20 weeks
gestation
How to Refer?
 Toll-free number at 877-311-8972 to refer patient
OR provide the patient our toll-free number
 Contact via email at [email protected]
 Fax a referral sheet to OTIS which is found on our
website at www.otispregnancy.org